Showing results (2271-2280 of 6,508) with videos related to
Sort By:
Pageof 651
Contraception|March 27, 2012
Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mgPeyman Hadji, Jutta Biskup, Jelena Boekhoff, et al.Contraception|March 27, 2012
Tailored health messaging improves contraceptive continuation and adherence: results from a randomized controlled trialSamantha Garbers, Allison Meserve, Melissa Kottke, et al.Contraception|September 17, 2011
Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrelAnna Glasier, Sharon T Cameron, Diana Blithe, et al.Contraception|September 17, 2011
The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent womenGeorg A K Schramm, Guido SchrahContraception|October 25, 2011
Unintended pregnancy in the United States: incidence and disparities, 2006Lawrence B Finer, Mia R ZolnaContraception|October 25, 2011
A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutismGokalp Oner, Iptisam Ipek MuderrisContraception|October 25, 2011
Development and evaluation of matrix type transdermal patch of ethinylestradiol and medroxyprogesterone acetate for anti-implantation activity in female Wistar ratsShyam Sunder Agrawal, Jatin Kumar PruthiContraception|October 25, 2011
Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraceptionSikolia Z Wanyonyi, William R Stones, Evan SequeiraContraception|June 14, 2011
Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trialsGilda Piaggio, Nathalie Kapp, Helena von HertzenContraception|June 14, 2011
Contraception choices in a cohort of HIV+ women in the era of highly active antiretroviral therapyEchezona E Ezeanolue, Paul G Stumpf, Evelen Soliman, et al.Pageof 651